![Takashi Kamimura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 669 248 $ op 31-05-2026
Takashi Kamimura worked as Director & Manager-Drug Discovery at Teijin Pharma Ltd. from 2009 to 2013.
Dr. Kamimura also worked as Director at Veritas In Silico Inc. from 2017 to 2019.
Former jobs include Director & Manager-Drug Discovery at Teijin Pharma Ltd. and Director at Veritas In Silico Inc.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-06-2025 | 256.100 ( 3,95% ) | 669 248 $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
Teijin Pharma Ltd.
 Teijin Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products & medical devices | Directeur/Bestuurslid | 31-03-2013 |
| VERITAS IN SILICO INC. | Operationeel Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Teijin Pharma Ltd.
Teijin Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products & medical devices | Health Technology |
Veritas In Silico Inc.
 Veritas In Silico Inc. BiotechnologyHealth Technology Develops drugs against structural motifs on mRNA | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
